But whats getting the spotlight right now are more than a dozen unapproved peptide drugs that, back in September 2023, the FDA added to its Category 2 Bulk Substances listthats a list of substances that the FDA says pose significant safety risks and are not eligible for compounding without further research
7.1.2 Personalized biomonitoring and risk stratification 7.1.2.1 Wearable biosensor technology Advancement of portable analytical devices for simplified detection of urinary EED metabolites, including rapid screening methods for BPA and phthalates in clinical and occupational settings (137)
First characterized in the early 1990s, it has been extensively studied in laboratory and animal models across more than 100 published papers

Athletes and active adults with stubborn connective tissue injuries tendinopathy, ligament sprains, or muscle tears that arent responding to PT or rest People managing chronic gut inflammation those dealing with GI issues, barrier dysfunction, or ulcer-related symptoms looking for adjunctive support Post-surgical patients seeking to optimize tissue healing and reduce inflammatory burden during recovery (with surgeon clearance) Wellness-focused individuals in the Johnson City and Tri-Cities area who are actively managing their health and want access to emerging regenerative options under medical supervision Biohackers and longevity-focused adults who have researched peptide therapy and want a provider with clinical oversight, verified compound sourcing, and a personalized protocol not a random online seller People already on complementary therapies like hormone optimization, IV therapy, or GLP-1 therapy who want to stack recovery tools strategically Multi-Site Recovery